SAB Biotherapeutics Statistics

Total Valuation

SABS has a market cap or net worth of $18.39 million. The enterprise value is $10.98 million.

Market Cap	18.39M
Enterprise Value	10.98M

Important Dates

The next estimated earnings date is Monday, May 19, 2025, after market close.

Earnings Date	May 19, 2025
Ex-Dividend Date	n/a

Share Statistics

SABS has 9.29 million shares outstanding. The number of shares has increased by 41.12% in one year.

Current Share Class	9.29M
Shares Outstanding	9.29M
Shares Change (YoY)	+41.12%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	20.27%
Owned by Institutions (%)	19.16%
Float	6.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.94
Forward PS	16.85
PB Ratio	0.78
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	29.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.31.

Current Ratio	1.69
Quick Ratio	1.33
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-135.73

Financial Efficiency

Return on equity (ROE) is -92.35% and return on invested capital (ROIC) is -61.24%.

Return on Equity (ROE)	-92.35%
Return on Assets (ROA)	-48.28%
Return on Invested Capital (ROIC)	-61.24%
Return on Capital Employed (ROCE)	-148.57%
Revenue Per Employee	$5,997
Profits Per Employee	-$544,069
Employee Count	63
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.88% in the last 52 weeks. The beta is 0.48, so SABS's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-49.88%
50-Day Moving Average	1.52
200-Day Moving Average	2.59
Relative Strength Index (RSI)	68.06
Average Volume (20 Days)	40,580

Short Selling Information

The latest short interest is 99,928, so 1.08% of the outstanding shares have been sold short.

Short Interest	99,928
Short Previous Month	71,517
Short % of Shares Out	1.08%
Short % of Float	1.55%
Short Ratio (days to cover)	3.19

Income Statement

In the last 12 months, SABS had revenue of $377,835 and -$34.28 million in losses. Loss per share was -$3.70.

Revenue	377,835
Gross Profit	-29.87M
Operating Income	-42.29M
Pretax Income	-40.32M
Net Income	-34.28M
EBITDA	-38.79M
EBIT	-42.29M
Loss Per Share	-$3.70

Full Income Statement

Balance Sheet

The company has $12.85 million in cash and $6.64 million in debt, giving a net cash position of $6.21 million or $0.67 per share.

Cash & Cash Equivalents	12.85M
Total Debt	6.64M
Net Cash	6.21M
Net Cash Per Share	$0.67
Equity (Book Value)	21.41M
Book Value Per Share	2.30
Working Capital	6.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.34 million and capital expenditures -$208,188, giving a free cash flow of -$31.55 million.

Operating Cash Flow	-31.34M
Capital Expenditures	-208,188
Free Cash Flow	-31.55M
FCF Per Share	-$3.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-11,193.25%
Pretax Margin	-9,071.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SABS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.12%
Shareholder Yield	-41.12%
Earnings Yield	-199.46%
FCF Yield	-183.58%

Analyst Forecast

The average price target for SABS is $11.40, which is 475.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.40
Price Target Difference	475.76%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	110.85%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 5, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 5, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1